Pluri (PLUR) Stock Chart & Stock Price History → Gold Mania (From Stansberry Research) (Ad) Free PLUR Stock Alerts $5.82 -0.14 (-2.35%) (As of 05/10/2024 ET) Add Compare Share Share ChartStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Pluri Stock Price Performance5 Day Performance-1.27%1 Month Performance+3.29%3 Month Performance-9.14%6 Month Performance+20.01%Year-To-Date Performance+25.43%1 Year Performance-19.24% Receive PLUR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Pluri and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Banyan Hill PublishingREAD THIS – If You Missed Out On The AI BoomAdam’s research shows a radical new technology is set to grow 10X faster than the internet … and drastically alter manufacturing, healthcare, agriculture … even energy. Nvidia’s CEO said it will be, “flat out, the biggest [tech] revolution ever.”Click on Adam's shiny forehead for more details. PLUR Stock Chart for Sunday, May, 12, 2024 PLUR Chart by TradingView Pluri Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/10/2024$5.65$5.82+2.92%$5.94$5.653,501 shs$30.15 million05/09/2024$5.85$5.65-3.42%$5.75$5.656,151 shs$29.30 million05/08/2024$5.89$5.85-0.68%$5.97$5.754,652 shs$30.33 million05/07/2024$5.60$5.89+5.18%$5.89$5.565,622 shs$30.54 million05/06/2024$5.75$5.60-2.61%$5.87$5.5321,704 shs$29.01 million05/03/2024$5.64$5.75+1.95%$5.77$5.646,355 shs$29.79 million Get the Latest News and Ratings for PLUR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Pluri and its competitors with MarketBeat's FREE daily newsletter. 05/02/2024$5.37$5.64+5.03%$5.90$5.4140,333 shs$29.24 million05/01/2024$5.60$5.37-4.11%$5.60$5.2121,387 shs$27.82 million04/30/2024$5.27$5.60+6.26%$5.60$5.1435,048 shs$29.01 million04/29/2024$5.36$5.27-1.62%$5.48$4.812,595 shs$27.30 million04/26/2024$4.90$5.25+7.14%$5.44$4.736,886 shs$27.20 million04/25/2024$5.09$4.90-3.73%$5.25$4.805,014 shs$25.38 million04/24/2024$5.00$5.09+1.80%$5.18$4.9711,601 shs$26.37 million04/23/2024$5.01$5.00-0.20%$5.09$4.998,559 shs$25.93 million04/22/2024$5.25$5.01-4.57%$5.51$5.018,524 shs$25.95 million04/19/2024$5.05$5.25+3.96%$5.34$4.8023,518 shs$27.20 million04/18/2024$5.17$5.05-2.32%$5.18$5.0012,141 shs$26.81 million04/17/2024$5.76$5.17-10.24%$5.47$4.7157,650 shs$26.78 million04/16/2024$5.67$5.76+1.59%$5.78$5.464,990 shs$29.84 million04/15/2024$5.75$5.67-1.39%$6.03$5.6313,179 shs$29.37 million04/12/2024$5.80$5.63-2.93%$5.77$5.4322,925 shs$29.16 million04/11/2024$5.96$5.80-2.68%$6.19$5.2558,395 shs$30.04 million04/10/2024$5.68$5.96+4.93%$6.26$5.5144,483 shs$30.87 million04/09/2024$5.60$5.68+1.43%$5.89$5.5138,387 shs$29.45 million04/08/2024$5.49$5.60+2.00%$6.09$5.26598,530 shs$29.01 million04/05/2024$5.00$5.49+9.80%$5.66$4.8223,896 shs$28.44 million04/04/2024$5.25$5.00-4.76%$5.12$4.5031,110 shs$25.93 million04/03/2024$5.62$5.25-6.58%$5.49$5.0141,071 shs$27.20 million04/02/2024$5.95$5.62-5.55%$5.85$5.4948,558 shs$233.12 million04/01/2024$6.45$5.95-7.72%$6.17$5.5057,198 shs$246.81 million03/29/2024$6.45$6.45$6.84$5.7769,090 shs$33.43 million03/28/2024$7.04$6.45-8.39%$6.84$5.7768,610 shs$33.43 million03/27/2024$8.16$7.04-13.75%$7.80$6.8057,256 shs$36.49 million03/26/2024$7.46$8.16+9.32%$8.40$7.6036,686 shs$42.31 million03/25/2024$7.60$7.46-1.78%$7.84$7.2213,361 shs$38.70 million03/22/2024$7.52$7.60+1.05%$7.72$6.856,033 shs$39.40 million03/21/2024$7.68$7.52-2.08%$7.76$7.2018,974 shs$38.99 million03/20/2024$7.56$7.68+1.59%$7.76$6.8113,766 shs$39.82 million03/19/2024$7.56$7.56$7.84$7.4411,075 shs$39.20 million03/18/2024$7.98$7.56-5.23%$8.00$7.486,665 shs$39.20 million[Webinar] A Deep Dive into Options Volatility: Skew & Relative Value (Ad)Join us for an exploration of essential volatility concepts in our "Volatility Fundamentals II: Skew & Relative Value" session. OIC® instructor Ken Keating will guide you through important topics that options investors should understand. Click here to register now (5/15 Webinar)03/15/2024$7.52$7.98+6.09%$8.16$7.325,440 shs$41.36 million03/14/2024$7.72$7.52-2.56%$7.83$7.366,903 shs$38.99 million03/13/2024$7.68$7.72+0.49%$8.48$7.368,554 shs$40.02 million03/12/2024$7.75$7.68-0.89%$8.16$7.206,699 shs$39.82 million03/11/2024$8.08$7.75-4.10%$8.16$7.2314,767 shs$40.18 million03/08/2024$7.70$8.08+5.00%$8.32$7.548,967 shs$41.90 million03/07/2024$8.00$7.70-3.81%$7.78$7.3612,451 shs$39.90 million03/06/2024$7.03$8.00+13.77%$8.32$6.6435,039 shs$41.48 million03/05/2024$6.72$7.03+4.64%$7.36$6.4818,789 shs$36.46 million03/04/2024$6.40$6.72+5.00%$6.72$6.166,440 shs$34.84 million03/01/2024$6.48$6.55+1.16%$6.56$6.103,737 shs$33.99 million02/29/2024$6.28$6.48+3.12%$6.56$6.295,692 shs$33.60 million02/28/2024$6.16$6.28+2.01%$6.40$6.0616,695 shs$32.58 million02/27/2024$5.89$6.16+4.61%$6.24$5.684,608 shs$31.94 million02/26/2024$5.98$5.89-1.54%$6.26$5.766,347 shs$30.53 million02/23/2024$5.80$5.98+3.03%$6.32$5.5216,842 shs$31.01 million02/22/2024$5.99$5.80-3.14%$6.17$5.647,974 shs$30.09 million02/21/2024$6.24$5.99-3.97%$6.72$5.929,421 shs$31.07 million02/20/2024$6.64$6.24-5.97%$6.55$6.084,533 shs$32.35 million02/19/2024$6.64$6.64$6.80$5.848,675 shs$34.41 million02/16/2024$6.16$6.34+2.96%$6.80$5.848,685 shs$32.89 million02/15/2024$5.97$6.16+3.13%$6.60$5.983,529 shs$31.94 million02/14/2024$5.92$5.97+0.88%$6.24$5.841,334 shs$30.97 million02/13/2024$6.40$5.92-7.49%$6.28$5.726,834 shs$30.70 million02/12/2024$6.22$6.40+2.87%$6.80$6.169,907 shs$33.18 million Related Companies: Surrozen Stock Chart NKGen Biotech Stock Chart MiNK Therapeutics Stock Chart Protara Therapeutics Stock Chart Achilles Therapeutics Stock Chart Cortexyme Stock Chart CASI Pharmaceuticals Stock Chart Brainstorm Cell Therapeutics Stock Chart Estrella Immunopharma Stock Chart SAB Biotherapeutics Stock Chart Receive PLUR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Pluri and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:PLUR) was last updated on 5/12/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsGold Set to EXPLODE!Gold Safe ExchangeCollapse of the Petrodollar Colonial MetalsHe Is Giving Away BitcoinCrypto Swap Profits[Webinar] A Deep Dive into Options Volatility: Skew & Relative ValueOICCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingMissed NVDA? Buy this AI stock NOWChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pluri Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.